We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Investigates Contaminant, FDA Panel to Review Rotarix
GSK Investigates Contaminant, FDA Panel to Review Rotarix
May 3, 2010
GlaxoSmithKline (GSK) is honing in on a possible source of the DNA fragments found in vials of its Rotarix vaccine as it prepares for an FDA advisory committee
meeting that will review the problem and consider possible solutions.